Login

Ownership

Who owns ACELYRIN, Inc., from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).

Stakes over 5%

Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.

Exited (13D) Trium Capital LLP May 27, 2025

Trium Capital LLP: 0.0% · 0 shares

Exited (13G) AyurMaya Capital Management Company, LP, David E. Goel May 23, 2025

AyurMaya Capital Management Company, LP: 0.0% · 0 shares — David E. Goel: 0.0% · 0 shares

6 more 5% stakes behind a free account

See every investor who has disclosed crossing 5% of ACELYRIN, Inc..

Sign up free

Super investors holding ACELYRIN, Inc.

Every institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of ACELYRIN, Inc. they hold. Together these 108 managers report 73.23% of shares outstanding.

Investor Position value Shares % of their portfolio % of company As of
TANG CAPITAL MANAGEMENT LLC $24.3M 9,818,115 1.34% 9.73% March 31, 2025
AyurMaya Capital Management Company, LP $23.1M 9,334,735 26.08% 9.25% March 31, 2025

106 more institutional holders behind a free account

See every manager reporting ACELYRIN, Inc., how much of the company they hold, and how big the position is inside their own portfolio.

Sign up free

Funds holding ACELYRIN, Inc.

Funds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 154 funds hold 20.94% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.

Fund Position value % of net assets % of company As of
T. Rowe Price Small-Cap Stock Fund, Inc. $11.4M 0.13% 3.59% December 31, 2024
T. Rowe Price Small-Cap Value Fund, Inc. $7M 0.07% 2.81% March 31, 2025

152 more funds behind a free account

See every fund holding ACELYRIN, Inc. and what share of its net assets the position represents.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support